ES2378177T3 - Derivado de carbazol, solvato del mismo o sal del mismo farmaceúticamente aceptable - Google Patents

Derivado de carbazol, solvato del mismo o sal del mismo farmaceúticamente aceptable Download PDF

Info

Publication number
ES2378177T3
ES2378177T3 ES05799893T ES05799893T ES2378177T3 ES 2378177 T3 ES2378177 T3 ES 2378177T3 ES 05799893 T ES05799893 T ES 05799893T ES 05799893 T ES05799893 T ES 05799893T ES 2378177 T3 ES2378177 T3 ES 2378177T3
Authority
ES
Spain
Prior art keywords
group
substituent groups
methoxy
substituent
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES05799893T
Other languages
English (en)
Spanish (es)
Inventor
Masakazu Murata
Yoshihiko Itokazu
Ryu Nakao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2378177T3 publication Critical patent/ES2378177T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES05799893T 2004-10-29 2005-10-28 Derivado de carbazol, solvato del mismo o sal del mismo farmaceúticamente aceptable Active ES2378177T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2004316872 2004-10-29
JP2004316872 2004-10-29
PCT/JP2005/020250 WO2006046779A1 (ja) 2004-10-29 2005-10-28 カルバゾール誘導体、その溶媒和物、又は薬学的に許容されるその塩

Publications (1)

Publication Number Publication Date
ES2378177T3 true ES2378177T3 (es) 2012-04-09

Family

ID=36227999

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05799893T Active ES2378177T3 (es) 2004-10-29 2005-10-28 Derivado de carbazol, solvato del mismo o sal del mismo farmaceúticamente aceptable

Country Status (16)

Country Link
US (1) US8329913B2 (US06720351-20040413-C00034.png)
EP (1) EP1852433B1 (US06720351-20040413-C00034.png)
JP (1) JP3997491B2 (US06720351-20040413-C00034.png)
KR (1) KR101223820B1 (US06720351-20040413-C00034.png)
CN (1) CN101048402B (US06720351-20040413-C00034.png)
AT (1) ATE534646T1 (US06720351-20040413-C00034.png)
AU (1) AU2005297800B2 (US06720351-20040413-C00034.png)
CA (1) CA2585642C (US06720351-20040413-C00034.png)
CY (1) CY1112649T1 (US06720351-20040413-C00034.png)
DK (1) DK1852433T3 (US06720351-20040413-C00034.png)
ES (1) ES2378177T3 (US06720351-20040413-C00034.png)
PL (1) PL1852433T3 (US06720351-20040413-C00034.png)
PT (1) PT1852433E (US06720351-20040413-C00034.png)
SI (1) SI1852433T1 (US06720351-20040413-C00034.png)
TW (1) TW200635922A (US06720351-20040413-C00034.png)
WO (1) WO2006046779A1 (US06720351-20040413-C00034.png)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7393181B2 (en) 2004-09-17 2008-07-01 The Penn State Research Foundation Expandable impeller pump
EP3520834B1 (en) 2006-03-23 2022-04-27 The Penn State Research Foundation Heart assist device with expandable impeller pump
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
BRPI0814294A2 (pt) 2007-07-19 2015-02-03 Metabolex Inc Agonistas de receptor heterocíclico ligado a n para o tratamento do diabetes e de desordens metabólicas.
CA2769631A1 (en) 2009-07-01 2011-01-06 The Penn State Research Foundation Blood pump with expandable cannula
WO2011041154A1 (en) 2009-10-01 2011-04-07 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
JP5847813B2 (ja) 2010-06-23 2016-01-27 シマベイ セラピューティクス, インコーポレーテッド 5−エチル−2−{4−[4−(4−テトラゾル−1−イル−フェノキシメチル)−チアゾール−2−イル]−ピペリジン−1−イル}−ピリミジンの組成物
CN102382037B (zh) * 2010-09-03 2016-01-20 中国医学科学院药物研究所 苯丙酸类化合物及其制法和药物用途
US8485961B2 (en) 2011-01-05 2013-07-16 Thoratec Corporation Impeller housing for percutaneous heart pump
US8597170B2 (en) 2011-01-05 2013-12-03 Thoratec Corporation Catheter pump
WO2012094641A2 (en) 2011-01-06 2012-07-12 Thoratec Corporation Percutaneous heart pump
WO2012094535A2 (en) 2011-01-06 2012-07-12 Thoratec Corporation Percutaneous heart pump
EP4218887A1 (en) 2012-05-14 2023-08-02 Tc1 Llc Mechanical circulatory support device for stabilizing a patient after cardiogenic shock
US9446179B2 (en) 2012-05-14 2016-09-20 Thoratec Corporation Distal bearing support
US9327067B2 (en) 2012-05-14 2016-05-03 Thoratec Corporation Impeller for catheter pump
US8721517B2 (en) 2012-05-14 2014-05-13 Thoratec Corporation Impeller for catheter pump
US9872947B2 (en) 2012-05-14 2018-01-23 Tc1 Llc Sheath system for catheter pump
US9421311B2 (en) 2012-07-03 2016-08-23 Thoratec Corporation Motor assembly for catheter pump
US9358329B2 (en) 2012-07-03 2016-06-07 Thoratec Corporation Catheter pump
EP4186557A1 (en) 2012-07-03 2023-05-31 Tc1 Llc Motor assembly for catheter pump
WO2014164136A1 (en) 2013-03-13 2014-10-09 Thoratec Corporation Fluid handling system
US11077294B2 (en) 2013-03-13 2021-08-03 Tc1 Llc Sheath assembly for catheter pump
US11033728B2 (en) 2013-03-13 2021-06-15 Tc1 Llc Fluid handling system
US9308302B2 (en) 2013-03-15 2016-04-12 Thoratec Corporation Catheter pump assembly including a stator
EP3797810A1 (en) 2013-03-15 2021-03-31 Tc1 Llc Catheter pump assembly including a stator
EP3799918A1 (en) 2014-04-15 2021-04-07 Tc1 Llc Sensors for catheter pumps
US10583232B2 (en) 2014-04-15 2020-03-10 Tc1 Llc Catheter pump with off-set motor position
WO2015160990A1 (en) 2014-04-15 2015-10-22 Thoratec Corporation Catheter pump introducer systems and methods
EP3479854A1 (en) 2014-04-15 2019-05-08 Tc1 Llc Catheter pump with access ports
EP3583973A1 (en) 2014-08-18 2019-12-25 Tc1 Llc Guide features for percutaneous catheter pump
US9675738B2 (en) 2015-01-22 2017-06-13 Tc1 Llc Attachment mechanisms for motor of catheter pump
US9770543B2 (en) 2015-01-22 2017-09-26 Tc1 Llc Reduced rotational mass motor assembly for catheter pump
WO2016118781A2 (en) 2015-01-22 2016-07-28 Thoratec Corporation Motor assembly with heat exchanger for catheter pump
US9907890B2 (en) 2015-04-16 2018-03-06 Tc1 Llc Catheter pump with positioning brace
US11491322B2 (en) 2016-07-21 2022-11-08 Tc1 Llc Gas-filled chamber for catheter pump motor assembly
US11160970B2 (en) 2016-07-21 2021-11-02 Tc1 Llc Fluid seals for catheter pump motor assembly
KR20190035752A (ko) 2016-08-03 2019-04-03 사이머베이 쎄라퓨틱스, 인코퍼레이티드 염증성 위장 질환 또는 위장 상태를 치료하기 위한 옥시메틸렌 아릴 화합물
CA3077273A1 (en) 2017-10-06 2019-04-11 Gilead Sciences, Inc. Combination therapy comprising an acc inhibitor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804416A1 (en) 1994-07-27 1997-11-05 Sankyo Company Limited Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors
JP2001503055A (ja) 1996-10-30 2001-03-06 イーライ・リリー・アンド・カンパニー 置換三環化合物群
MY125942A (en) * 1999-09-07 2006-09-29 Upjohn Co Aminoalkoxy carbazoles for the treatment of cns diseases
WO2001026653A1 (fr) 1999-10-15 2001-04-19 Shionogi & Co., Ltd. Inhibiteurs spla2 du type v et/ou du type x
WO2002000257A1 (fr) 2000-06-29 2002-01-03 Shionogi & Co., Ltd. Remedes a la maladie d'alzheimer
US6967200B2 (en) 2000-06-29 2005-11-22 Shionogi & Co., Ltd. Remedies for cirrhosis
AU2001267824A1 (en) 2000-06-29 2002-01-08 Shionogi And Co., Ltd. Remedies for cancer
TWI314457B (US06720351-20040413-C00034.png) 2001-03-19 2009-09-11 Shionogi & Co
JP2004525154A (ja) 2001-03-28 2004-08-19 イーライ・リリー・アンド・カンパニー sPLA2インヒビターとしての置換カルバゾール
WO2004024939A2 (en) * 2002-09-13 2004-03-25 Georgetown University Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
US7268157B2 (en) * 2002-11-26 2007-09-11 Shenzhen Chipscreen Biosciences, Ltd. Substituted arylalcanoic acid derivatives as PPAR pan agonists with potent antihyperglycemic and antihyperlipidemic activity

Also Published As

Publication number Publication date
EP1852433B1 (en) 2011-11-23
US20100286210A1 (en) 2010-11-11
DK1852433T3 (da) 2012-01-30
CA2585642C (en) 2013-04-02
KR20070072554A (ko) 2007-07-04
JP3997491B2 (ja) 2007-10-24
JPWO2006046779A1 (ja) 2008-05-22
US8329913B2 (en) 2012-12-11
EP1852433A4 (en) 2010-07-21
PT1852433E (pt) 2012-02-08
CN101048402A (zh) 2007-10-03
EP1852433A1 (en) 2007-11-07
CY1112649T1 (el) 2016-02-10
ATE534646T1 (de) 2011-12-15
AU2005297800B2 (en) 2011-02-03
WO2006046779A1 (ja) 2006-05-04
AU2005297800A1 (en) 2006-05-04
TW200635922A (en) 2006-10-16
TWI359148B (US06720351-20040413-C00034.png) 2012-03-01
PL1852433T3 (pl) 2012-05-31
KR101223820B1 (ko) 2013-01-17
CA2585642A1 (en) 2006-05-04
SI1852433T1 (sl) 2012-06-29
CN101048402B (zh) 2011-11-09

Similar Documents

Publication Publication Date Title
ES2378177T3 (es) Derivado de carbazol, solvato del mismo o sal del mismo farmaceúticamente aceptable
JP5580201B2 (ja) グルコキナーゼアクチベータとしてのアセトアミド誘導体、その製法及び医薬応用
AU2004255342C1 (en) Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds
EP2155720B1 (en) Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application
JP4276074B2 (ja) ペルオキシソーム増殖剤応答性受容体δの活性化剤
SK14922003A3 (sk) Modulátory receptorov aktivovaných proliferátormi peroxizómov (PPAR)
KR20050119201A (ko) 5원 헤테로방향족 고리 화합물 및 이의 의약적 용도
WO2002053547A1 (fr) Derives d'acide alcanoique, procede de production et utilisation correspondants
KR20080040046A (ko) 티아졸 유도체
WO2004106276A1 (ja) 縮合環化合物
JPWO2002046176A1 (ja) ペルオキシソーム増殖剤応答性受容体の活性化剤
MX2011000044A (es) Compuesto heterociclilo aromatico que contiene nitrogeno.
NO323922B1 (no) Heterosykliske forbindelser og farmasoytisk middel omfattende samme
JP2013230986A (ja) 新規ヒダントイン誘導体及びそれらを有効成分とする医薬
JPWO2002046161A1 (ja) 置換カルボン酸誘導体
CN101304984A (zh) 唑和噻唑ppar调节剂
WO2012038904A1 (fr) Derives de nicotinamide, leur preparation et leur application en therapeutique
WO2006117743A1 (en) Substituted aromatic compounds as antidiabetic agents
JPWO2009025265A1 (ja) ピペラジン誘導体
JP3466273B2 (ja) テトラゾール誘導体、その製造法およびそれを含んでなる医薬
WO2005095364A1 (ja) フェノキシ酢酸誘導体及びそれを用いた医薬
WO2021070957A1 (ja) ベンゼン縮合環化合物、およびそれを含有する医薬組成物